Late Sodium Current Blockade in High-Risk ICD Patients

Trial Profile

Late Sodium Current Blockade in High-Risk ICD Patients

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Mar 2017

At a glance

  • Drugs Ranolazine (Primary)
  • Indications Arrhythmias; Cardiomyopathies; Heart failure
  • Focus Therapeutic Use
  • Acronyms RAID
  • Most Recent Events

    • 24 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 28 Sep 2016 Planned End Date changed from 1 Feb 2017 to 1 Sep 2017.
    • 30 Dec 2015 Planned End Date changed from 1 Oct 2015 to 1 Feb 2017, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top